Photodynamic Therapy as an Oxidative Anti-Tumor Modality: Negative Effects of Nitric Oxide on Treatment Efficacy
Open Access
- 21 April 2021
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (5) , 593
Abstract
Anti-tumor photodynamic therapy (PDT) is a unique oxidative stress-based modality that has proven highly effective on a variety of solid malignancies. PDT is minimally invasive and generates cytotoxic oxidants such as singlet molecular oxygen (1O2). With high tumor site-specificity and limited off-target negative effects, PDT is increasingly seen as an attractive alternative or follow-up to radiotherapy or chemotherapy. Nitric oxide (NO) is a short-lived bioactive free radical molecule that is exploited by many malignant tumors to promote cell survival, proliferation, and metastatic expansion. Typically generated endogenously by inducible nitric oxide synthase (iNOS/NOS2), low level NO can also antagonize many therapeutic interventions, including PDT. In addition to elevating resistance, iNOS-derived NO can stimulate growth and migratory aggressiveness of tumor cells that survive a PDT challenge. Moreover, NO from PDT-targeted cells in any given population is known to promote such aggressiveness in non-targeted counterparts (bystanders). Each of these negative responses to PDT and their possible underlying mechanisms will be discussed in this chapter. Promising pharmacologic approaches for mitigating these NO-mediated responses will also be discussed.Keywords
Funding Information
- U.S. Public Health Service (CA70823)
- Bird Studies Canada (FP12605)
- Rock River (FP14869)
This publication has 87 references indexed in Scilit:
- Protein S-nitrosylation: Role for nitric oxide signaling in neuronal deathBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancerTrends in Pharmacological Sciences, 2011
- NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegenerationMolecular Neurodegeneration, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapyFree Radical Biology and Medicine, 2010
- The chemical biology of nitric oxide: Implications in cellular signalingFree Radical Biology and Medicine, 2008
- Role of TGF-β1 and nitric oxide in the bystander response of irradiated glioma cellsOncogene, 2007
- Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulinBritish Journal of Cancer, 2006
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Vitamin E as an in Vitro and in Vivo AntioxidantaAnnals of the New York Academy of Sciences, 1989